Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CLDT vs BHR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CLDT Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)

CLDT Overall Winner 6-Pillar Tally: CLDT 4 – 2 BHR Matrix Metrics: CLDT 8 – 2 BHR

As of Nov 20, 2026, Chatham Lodging Trust (CLDT) is the stronger overall head-to-head candidate over Braemar Hotels & Resorts Inc. (BHR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CLDT carries a Unified Composite Score of 46.5/100 (HOLD) at $15.36 (N/M Forward P/E, 11.2% operating margin), whereas BHR carries 36.1/100 (SELL) at $1.42 (20.6x Forward P/E, 4.6% operating margin).

  • Technical & Structure Timing Caution: CLDT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 52.7); meanwhile BHR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CLDT vs BHR
CLDT NYSE Head-to-Head Winner
Chatham Lodging Trust
Real Estate Investment Trusts
$15.36
-0.84% 1D
Market Cap $758.5M
TTM Revenue $155M
Forward P/E N/M
Beta / 30D Vol 0.32β · 26% Vol
Unified Composite Score
46.5 / 100 HOLD
Tech 38.0 Fund 48.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.8% over 20 days), RSI 53
RSI-14: 52.7 · SMA20: $15.48 · SMA50: $14.33
BHR NYSE
Braemar Hotels & Resorts Inc. Common Stock
Real Estate Investment Trusts
$1.42
-5.96% 1D
Market Cap $110.9M
TTM Revenue $647M
Forward P/E 20.6x
Beta / 30D Vol 0.50β · 63% Vol
Unified Composite Score
36.1 / 100 SELL
Tech 15.0 Fund 40.0 Flow 56.0 Mom 44.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.8%), weak momentum, RSI 41
RSI-14: 41.3 · SMA20: $1.51 · SMA50: $1.55

6-Pillar Scorecard Institutional Category Breakdown (CLDT 4 – 2 BHR)

Columns: Metric · CLDT · BHR
1. Valuation Multiples BHR
Forward P/E N/M 20.6x
Trailing P/E 96.8x 20.6x
PEG Ratio 2.28x N/M
EV / Revenue 4.9x 0.2x
2. Growth & Scale CLDT
Revenue Growth (YoY) +16.0% -29.2%
Earnings Growth (YoY) +266.7% +7.1%
TTM Revenue (USD) $155M $647M
Market Cap $758.5M $110.9M
3. Profitability & Quality CLDT
Gross Margin 49.4% 27.4%
Operating Margin 11.2% 4.6%
Net Profit Margin 5.0% -37.4%
Return on Equity (ROE) 2.1% -62.0%
4. Balance Sheet & Cash Flow CLDT
Cash Generation (TTM) $48M EBITDA $45M
Cash Flow Margin 30.7% EBITDA Mgn 7.0%
Net Cash / Leverage $15.52 Book/Sh · 2.1% ROE -62.0% ROE
Dividend Yield 2.45% 3.25%
5. Options & Positioning BHR
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 12.5% (50th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CLDT
OpEx & R&D Intensity 38.2% of Rev ($59M) 22.8% of Rev ($148M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role REIT - Hotel & Motel Operator REIT - Hotel & Motel Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CLDT (8) vs BHR (2)
Institutional Metric CLDT BHR Criterion Row Edge
Market Capitalization
Scale
$758.5M $110.9M Larger Scale CLDT
Trailing P/E Ratio
Valuation
96.8x 20.6x Lower Multiple BHR
Forward P/E Ratio
Valuation
N/M 20.6x Lower Multiple BHR
Revenue Growth (YoY)
Growth
+16.0% -29.2% Higher Growth CLDT
Operating Margin (TTM)
Profitability
11.2% 4.6% Higher Margin CLDT
Net Profit Margin
Profitability
5.0% -37.4% Higher Margin CLDT
Return on Equity (ROE)
Capital Efficiency
2.1% -62.0% Higher ROE CLDT
52-Week Range Position
Momentum
88% ($6–$17) 12% ($1–$3) Stronger Trend CLDT
Beta / 30D Volatility
Risk Regime
0.32β · 26% Vol 0.50β · 63% Vol Lower Realized Risk CLDT
Unified Institutional Score
Composite Signal
46.5 / 100 (HOLD) 36.1 / 100 (SELL) Higher Composite CLDT
Trailing 12M Revenue (USD)
Operating Scale
$155M $647M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
49.4% 27.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.28x PEG · 4.9x EV/Rev N/M PEG · 0.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$48M EBITDA ($15.52 Book/Sh · 2.1% ROE) $45M (-62.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CLDT +8.49 pp
CLDT: +7.79% · BHR: -0.7%
3M Horizon CLDT +42.12 pp
CLDT: +11.39% · BHR: -30.73%
6M Horizon CLDT +86.52 pp
CLDT: +43.55% · BHR: -42.97%
1Y Horizon CLDT +185.95 pp
CLDT: +137.4% · BHR: -48.55%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CLDT vs BHR. Trailing 12-month operating profitability (CLDT 11.2% vs BHR 4.6%) and valuation multiples (CLDT N/M vs BHR 20.6x Forward P/E) are benchmarked directly in Pillar 4 below.

CLDT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$155M
Gross Margin49.4%
Op. Margin11.2%
ROE / Fwd P/E2.1% · N/M
BHR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$647M
Gross Margin27.4%
Op. Margin4.6%
ROE / Fwd P/E-62.0% · 20.6x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CLDT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CLDT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BHR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 12.5%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CLDT Moat Profile Cyclical / Execution-Driven Positioning
REIT - Hotel & Motel Operator
Competes within the REIT - Hotel & Motel value chain with $758.5M market capitalization and 11.2% operating margin.
OpEx & R&D Reinvestment 38.2% of Rev ($59M)
90D Engineering Disclosures 0 Published
BHR Moat Profile Cyclical / Execution-Driven Positioning
REIT - Hotel & Motel Operator
Competes within the REIT - Hotel & Motel value chain with $110.9M market capitalization and 4.6% operating margin.
OpEx & R&D Reinvestment 22.8% of Rev ($148M)
90D Engineering Disclosures 0 Published

Investor FAQ CLDT vs BHR Key Questions & Quantitative Answers

As of Nov 20, 2026, Chatham Lodging Trust (CLDT) is the stronger overall head-to-head candidate over Braemar Hotels & Resorts Inc. (BHR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CLDT carries a Unified Composite Score of 46.5/100 (HOLD) at $15.36 (N/M Forward P/E, 11.2% operating margin), whereas BHR carries 36.1/100 (SELL) at $1.42 (20.6x Forward P/E, 4.6% operating margin). Technical & Structure Timing Caution: CLDT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 52.7); meanwhile BHR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CLDT leads the Growth & Scale pillar: CLDT posts +16.0% YoY revenue growth and +266.7% YoY earnings growth on $155M TTM revenue (49.4% gross margin, 11.2% operating margin), compared with BHR at -29.2% YoY revenue growth and +7.1% YoY earnings growth on $647M TTM revenue (27.4% gross margin, 4.6% operating margin). On trailing 12-month operating scale, CLDT generates $155M in USD-normalized revenue versus $647M for BHR. In operating R&D and SG&A reinvestment, CLDT deploys 38.2% of Rev ($59M) (0 90-day corporate R&D disclosures) versus 22.8% of Rev ($148M) (0 disclosures) for BHR.

BHR screens cheaper on headline valuation multiples. CLDT trades at N/M Forward P/E, 96.8x Trailing P/E, 2.28x PEG, and 4.9x EV/Revenue (30.7% EBITDA margin), whereas BHR trades at 20.6x Forward P/E, 20.6x Trailing P/E, N/M PEG, and 0.2x EV/Revenue (7.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CLDT (2.1% ROE) versus BHR (-62.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CLDT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.32β · 26% Vol realized risk). By comparison, BHR carries 12.5% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.50β · 63% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.